RAS mutation
2 stories
-
healthPancreatic Cancer Pill Doubles Survival, Canada Trial Eyed
A daily pill, daraxonrasib, doubles survival for pancreatic cancer patients. Canadian doctors seek clinical trials.
-
healthPan-RAS Inhibitor Shows Survival Gain in Pancreatic Cancer
Daraxonrasib, a pan-RAS inhibitor, demonstrated improved survival and tumor control in advanced pancreatic cancer in early trials.